Sept 30 (Reuters) – Gerresheimer reported a sequential recovery in its second-quarter revenue on Wednesday, sending its shares 8% higher in early trading, as demand for its drug delivery devices boosted sales.
The German drug-packaging maker reported preliminary revenue of €578 million ($656.09 million) for the second quarter, up from €474.9 million in first quarter of the financial year.
The company’s half-year earnings before interest, taxes, depreciation and amortisation fell to €168 million from €210.4 million a year ago, but it reiterated that it expected the second half of the year to be stronger, after cutting its outlook in June.
($1 = 0.8810 euros)
(Reporting by Kira Britten and Danny Callaghan in Gdansk, editing by Milla Nissi-Prussak)
